1. Swerdlow SH, Campo E, editors. WHO classification of tumours of hematopoietic and lymphoid tissues. Lyon: IARC;2008. p. 155.
2. Swerdlow SH, Campo E, editors. WHO classification of tumours of hematopoietic and lymphoid tissues. 4th ed. Lyon: IARC;2017. p. 213.
3. Oshimi K. Progress in understanding and managing natural killer-cell malignancies. Br J Haematol. 2007; 139:532–544. PMID:
17916099.
4. Koita H, Suzumiya J, Ohshima K, Takeshita M, Kimura N, Kikuchi M, et al. Lymphoblastic lymphoma expressing natural killer cell phenotype with involvement of the mediastinum and nasal cavity. Am J Surg Pathol. 1997; 21:242–248. PMID:
9042293.
5. Petrella T, Bagot M, Willemze R, Beylot-Barry M, Vergier B, Delaunay M, et al. Blastic NK-cell lymphomas (agranular CD4+CD56+hematodermic neoplasms): a review. Am J Clin Pathol. 2005; 123:662–675. PMID:
15981806.
6. Petrella T, Comeau MR, Maynadié M, Couillault G, De Muret A, Maliszewski CR, et al. ‘Agranular CD4+CD56+ hematodermic neoplasm’ (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol. 2002; 26:852–862. PMID:
12131152.
7. Freud AG, Caligiuri MA. Human natural killer cell development. Immunol Rev. 2006; 214:56–72. PMID:
17100876.
8. Jain S, Kumar R, Purohit A, Pati HP. Precursor NK cell lymphoblastic leukemia/lymphoma-report of a case with literature review. Indian J Hematol Blood Transfus. 2014; 30(S1):283–285. PMID:
25332598.
9. Sedick Q, Alotaibi S, Alshieban S, Naheet KB, Elyamany G. Natural killer cell lymphoblastic leukaemia/lymphoma: Case report and review of the recent literature. Case Rep Oncol. 2017; 10:588–595. PMID:
28868017.